Results-driven professional with extensive expertise in leadership, project management, and strategic planning. Proven track record in clinical development and operations, adept at leading and managing global clinical trials across phases I-IV in EMEA, the Americas, and Asia-Pacific. With nearly 20 years of comprehensive experience in clinical and pre-clinical research, excel in complex problem analysis, decision-making, and risk assessment to enhance operational excellence and quality assurance.
Proficient in all stages of clinical trials, including study concept design, protocol writing, feasibility assessments, start-up, monitoring, close-out, final report preparation, and submissions. Demonstrated skills in budget management and cost optimization, with a strong emphasis on clinical innovations. Highly experienced in managing and overseeing CROs and other vendors, as well as procurement processes.
Key therapeutic areas of expertise include Neuroscience, Oncology/Haematology, Metabolic Diseases, Cardiology, Immunology, Infectious Diseases, Nephrology, and Rare Diseases. Possesses in-depth knowledge of ICH guidelines, GCP, the drug development process, and regulatory aspects related to decentralized trials and patient engagement.
Fluent in English, Polish, and Spanish, with a strong cultural sensitivity. Dedicated to utilizing my skills to make meaningful contributions to organizational success
2025 - Patient Engagement E- learning Program -DIA
2022 - Project & Portfolio Management for Pharmaceuticals – marcusevans Virtual Course
2021 - Critical Thinking During Risk Assessment - Webinar
2020 - Virtual Clinical Trial – Webinar
2018 - Building Relationship Versatility - Social Styles at Work
2017- Effective Presentations
2016- PTI - Budget Management Clinical Trial
2015- Virtual Team Management
2012- Risk Based Monitoring
2009- ICH - GCP training
2007- PPD Foundation - Introduction to Monitoring Clinical Trials